Does INSULIN GLARGINE Cause Atrophy? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Atrophy have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.0% of all adverse event reports for INSULIN GLARGINE.
8
Reports of Atrophy with INSULIN GLARGINE
0.0%
of all INSULIN GLARGINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Atrophy From INSULIN GLARGINE?
Of the 8 reports, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Atrophy Listed in the Official Label?
Yes, Atrophy is listed as a known adverse reaction in the official FDA drug label for INSULIN GLARGINE.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Atrophy?
ADALIMUMAB (76)
ETANERCEPT (43)
METHOTREXATE (37)
TRIAMCINOLONE ACETONIDE (36)
METHYLPREDNISOLONE (34)
INTERFERON BETA-1A (33)
ALENDRONATE (32)
SECUKINUMAB (30)
RITUXIMAB (29)
FINGOLIMOD (28)
Which INSULIN GLARGINE Alternatives Have Lower Atrophy Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO